Klimadynon (Dry Extract From Cimicifuga Racemosa (L.) Nutt., Rhizoma (Black Cohosh) (5-10:1), Extraction Solvent)

The dry extract of Cimicifuga racemosa contains bioactive compounds that may modulate serotonin receptors and exhibit weak estrogenic activity. These mechanisms are thought to influence the hypothalamic regulation of body temperature and reduce inflammatory mediators, which together can lessen hot flashes and related discomfort.

The appropriate dose of Klimadynon is determined by a qualified healthcare professional based on individual needs, health status, and local regulatory guidance. Patients should follow the prescriber's instructions and the product label without altering the regimen on their own.

Safety data for Klimadynon in pregnancy and lactation are limited. It is generally advised to avoid use during pregnancy and to consult a physician before using while breastfeeding, as the potential effects on the fetus or infant are not well established.

To place an order, submit an enquiry on the Klimadynon product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Klimadynon’s active ingredient, black cohosh extract, is distinct from phytoestrogenic supplements such as soy isoflavones. While both aim to reduce menopausal symptoms, black cohosh is thought to act primarily through serotonergic pathways rather than direct estrogen receptor binding, offering an alternative mechanism for women seeking non‑hormonal options.

Klimadynon should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, excessive heat and direct sunlight to maintain its potency and stability throughout its shelf life.

Klimadynon is taken orally, typically as a capsule or tablet, with water. It is usually consumed with or without food as directed by a healthcare professional. The exact administration schedule should follow the prescriber's guidance.

The most serious potential risks include rare cases of liver injury, manifested by jaundice or elevated liver enzymes, and severe allergic reactions such as anaphylaxis. Users should promptly report any signs of hepatic dysfunction or hypersensitivity to their healthcare provider.

Individuals with known hypersensitivity to black cohosh, those with active liver disease, pregnant women, and patients taking certain hepatotoxic or hormone‑affecting medications should avoid Klimadynon unless a physician determines it is safe.